Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI). Clinical studies have shown that centanafadine significantly reduces core symptoms of ADHD in ...
David Shephard and his team of two doctorate students are looking for 200 students for their clinical trial using virtual ...
Research suggests that certain bacteria in the gut have a direct effect on how you think and feel, and the gut microbiome is ...
ADHD medication being recalled nationwide after failing effectiveness tests - Lisdexamfetamine dimesylate is the generic form of Vyvanse ...
This post is in response to A Psychiatric Diagnosis is Not a Disease By Jonathan Shedler Ph.D. Jonathan Shedler's article clears up widespread misunderstanding about psychiatric diagnoses. Psychiatric ...
Demonstrated substantial and statistically significant improvement in ADHD symptoms as measured by the AISRS total score compared to placebo (p=0.039, primary endpoint, 150 mg solriamfetol) ...
Solriamfetol 150 mg showed a 45% mean reduction in ADHD symptoms at Week 6, with a significant AISRS score drop versus placebo (p=0.039). Clinical response (≥30% AISRS improvement) was achieved by ...
A new study finds that children with congenital heart disease and ADHD can take stimulant medications without fear of significant cardiovascular side effects. In a study to be presented at a national ...
Welcome to Childhood Made Crazy, an interview series that takes a critical look at the current “mental disorders of childhood” model. This series is comprised of interviews with practitioners, parents ...
A new, small study suggests children with autism, ADHD, and anorexia share similarly disrupted gut microbiomes, which, by ...